Invention Grant
- Patent Title: Vaccine for protection against ETEC-induced diarrhea comprising dmLT
-
Application No.: US16773713Application Date: 2020-01-27
-
Publication No.: US11052143B2Publication Date: 2021-07-06
- Inventor: Ann-Mari Svennerholm , Joshua Tobias , Nils Carlin , Jan Holmgren
- Applicant: SCANDINAVIAN BIOPHARMA HOLDING AB
- Applicant Address: SE Solna
- Assignee: SCANDINAVIAN BIOPHARMA HOLDING AB
- Current Assignee: SCANDINAVIAN BIOPHARMA HOLDING AB
- Current Assignee Address: SE Solna
- Agency: Knobbe, Martens, Olson & Bear LLP
- Main IPC: A61K39/108
- IPC: A61K39/108 ; A61K45/00 ; A61K47/00 ; A01N63/00 ; A61K48/00 ; A61K9/00 ; A61K39/00
Abstract:
An oral vaccine for immunization against ETEC-induced diarrhea, comprising inactivated Escherichia coli cells expressing an ETEC colonization factor antigen and dmLT protein adjuvant, wherein the vaccine preferably comprises less than 1013 cells per unit dose.
Public/Granted literature
- US20200215173A1 VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT Public/Granted day:2020-07-09
Information query
